Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 5, 2002, Pages 1314-1321

  Huang, Eugene H ^a   Pollack, Alan ^b   Levy, Larry ^a   Starkschall, George ^a   Dong, Lei ^a   Rosen, Isaac ^a   Kuban, Deborah A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Conformal radiotherapy; Dose volume effects; Prostate cancer; Rectal toxicity

Indexed keywords

DOSIMETRY; RADIOTHERAPY; REGRESSION ANALYSIS; TOXICITY;

PROSTATE CANCER;

ONCOLOGY;

ADULT; AGED; ANALYTIC METHOD; ANATOMY; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CHRONIC TOXICITY; CLINICAL FEATURE; COMPUTER ASSISTED RADIOTHERAPY; CORRELATION ANALYSIS; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DOSIMETRY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEMORRHOID; HISTOGRAM; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIATION ENTEROPATHY; RANK SUM TEST; RECTUM; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TARGET ORGAN; TREATMENT PLANNING;

AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY, CONFORMAL; RECTUM; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 2242453286     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03742-2     Document Type: Article

References (27)

1. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer Preliminary results of a randomized trial . Int J Radiat Oncol Biol Phys. 48:2000;635-642.
2. Michalski J.M., Purdy J.A., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys. 46:2000;391-402.
3. Lee W., Hanks G., Hanlon A. Lateral shielding reduces rectal morbidity following high-dose 3D conformal radiotherapy for clinically localized prostate cancer Further evidence for a significant dose effect . Int J Radiat Oncol Biol Phys. 35:1996;251-257.
4. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose conformal radiotherapy for prostate cancer using dose-volume histograms. Int J Radiat Oncol Biol Phys. 41:1998;83-92.
5. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 166:2001;876-881.
6. Schultheiss T.E., Hanks G.E., Hunt M.A., et al. Incidence and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. Int J Radiat Oncol Biol Phys. 32:1995;643-649.
7. Schultheiss T.E., Lee R., Hunt M., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;3-11.
8. Benk V.A., Adams J.A., Shipley W.U., et al. Late rectal bleeding following combined x-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. Int J Radiat Oncol Biol Phys. 26:1993;551-557.
9. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer (II) Volume effects and dose-volume histograms . Int J Radiat Oncol Biol Phys. 49:2001;685-698.
10. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I) Multivariate analysis and dose-response . Int J Radiat Oncol Biol Phys. 47:2000;103-113.
11. Wachter S., Gerstner N., Goldner G., et al. Rectal sequelae after conformal radiotherapy of prostate cancer Dose-volume histograms as predictive factors . Radiother Oncol. 59:2001;65-70.
12. Pollack A., Zagars G.K., Starkschall G., et al. Conventional vs. conformal radiotherapy for prostate cancer preliminary results of dosimetry and acute toxicity . Int J Radiat Oncol Biol Phys. 34:1996;555-564.
13. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
14. Pavy J.J., Denekamp J., Letschert J. Late effects toxicity scoring The SOMA scale . Int J Radiat Oncol Biol Phys. 31:1995;1043-1049.
15. Hanlon A.L., Schultheiss T.E., Hunt M.A. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys. 38:1997;59-63.
16. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 18:2000;3904-3911.
17. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
18. Peto R., Pike M.C., Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer. 35:1977;1-39.
19. Herold D.M., Hanlon A.L., Hanks G.E. Diabetes mellitus A predictor for late radiation morbidity . Int J Radiat Oncol Biol Phys. 43:1999;475-479.
20. Teshima T., Hanks G.E., Hanlon A.L., et al. Rectal bleeding after conformal 3D treatment of prostate cancer Time to occurrence, response to treatment and duration of morbidity . Int J Radiat Oncol Biol Phys. 39:1997;77-83.
21. Hartford A.C., Niemierko A., Adams J.A., et al. Conformal irradiation of the prostate Estimating long-term rectal bleeding risk using dose-volume histograms . Int J Radiat Oncol Biol Phys. 36:1996;721-730.
22. Melian E., Mageras G.S., Fuks Z., et al. Variation in prostate position quantification and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys. 38:1997;73-81.
23. Balter J.M., Sandler H.M., Lam K., et al. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys. 31:1995;113-118.
24. Mageras G.S., Kutcher G.J., Leibel S.A., et al. A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans. Int J Radiat Oncol Biol Phys. 35:1996;333-342.
25. Zelefsky M.J., Happersett L., Leibel S.A., et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 37:1997;13-19.
26. Huang E., Dong L., Chandra A., et al. Intrafraction motion during IMRT for prostate cancer. [Abstract] Int J Radiat Oncol Biol Phys. 51:(Suppl. 1):2001;212-213.
27. Chandra A., Dong L., Huang E., et al. Evaluation of ultrasound-based daily prostate localization during IMRT for prostate cancer. [Abstract] Int J Radiat Oncol Biol Phys. 51:(Suppl. 1):2001;167-168.